This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meluzín, J. Search for Related Content PubMed PubMed Citation Articles by Meluzín, J.

Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction

Jaroslav Meluzín, MD, PhD^a, Jan ern, MD, Prof^*, Milan Frélich, MD, PhD^*, Frantiek ttka, MD^*, Lenka pinarová, MD^a, Jana Popelová, MD, PhD, Roman típal, MD, PhD on behalf of the Investigators of This Multicenter Study

^a 1st Internal Department, Brno, Czech Republic
^* Center of Cardiovascular and Transplant Surgery, Brno, Czech Republic
Internal Department of the Faculty Hospital Motol, Prague, Czech Republic
Internal Department of the Faculty Hospital, Ostrava, Czech Republic

View larger version (11K): [in a new window]   Figure 1 Kaplan–Meier curves showing survival free of cardiac events (including death, nonfatal MI, unstable AP requiring hospitalization and hospitalization for heart failure) in groups A, B and C patients. Event-free survival was significantly better in group A than in group B or group C, both being p < 0.05.

View larger version (11K): [in a new window]   Figure 2 Kaplan–Meier curves demonstrating infarction-free survival in groups A, B and C patients. There were no significant differences among groups.

View larger version (11K): [in a new window]   Figure 3 Kaplan–Meier curves showing survival in groups A, B and C patients. There were no significant differences among groups.